Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LEVINE

Showing results (511-520 of 2,268) with videos related to

Pageof 227
Sort By:
Genes & Development|August 3, 2017
The interplay between epigenetic changes and the p53 protein in stem cellsArnold J Levine, Shelley L Berger
Cancer Research|January 19, 1999
Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award LectureD A Freedman, A J Levine
The Journal of Nutrition|January 21, 2006
Overall discussion: gaps and suggestions. Understanding tolerable upper intake levelsLouise A Berner, Marci J Levine
Peptide Research|November 1, 1996
Solid-phase synthesis and characterization of human salivary statherin: a tyrosine-rich phosphoprotein inhibitor of calcium phosphate precipitationT L Gururaja, M J Levine
Advances in Psychosomatic Medicine|January 1, 1985
Psychiatric aspects of cigarette smokingD J Levine, R W Johnson
Current Opinion in Genetics & Development|February 1, 1995
Oncogenes and cell proliferationA J Levine, J R Broach
Journal of Psychosomatic Research|February 1, 1994
A two factor model of denial of illness: a confirmatory factor analysisJ Levine, T Rudy, R Kerns
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1994
The properties of p53 proteins selected for the loss of suppression of transformationD C Olson, A J Levine
Psychiatric Services (Washington, D.C.)|April 27, 2000
Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998L Citrome, J Levine, B Allingham
Clinical Research|January 13, 1975
Position statement of the American Federation for Clinical Research on the DHEW proposed rules on protection of human subjectsR J Levine, R A Kreisberg
Pageof 227

Showing results (511-520 of 2,268) with videos related to

Sort By:
Pageof 227
Genes & Development|August 3, 2017
The interplay between epigenetic changes and the p53 protein in stem cellsArnold J Levine, Shelley L Berger
Cancer Research|January 19, 1999
Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award LectureD A Freedman, A J Levine
The Journal of Nutrition|January 21, 2006
Overall discussion: gaps and suggestions. Understanding tolerable upper intake levelsLouise A Berner, Marci J Levine
Peptide Research|November 1, 1996
Solid-phase synthesis and characterization of human salivary statherin: a tyrosine-rich phosphoprotein inhibitor of calcium phosphate precipitationT L Gururaja, M J Levine
Advances in Psychosomatic Medicine|January 1, 1985
Psychiatric aspects of cigarette smokingD J Levine, R W Johnson
Current Opinion in Genetics & Development|February 1, 1995
Oncogenes and cell proliferationA J Levine, J R Broach
Journal of Psychosomatic Research|February 1, 1994
A two factor model of denial of illness: a confirmatory factor analysisJ Levine, T Rudy, R Kerns
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1994
The properties of p53 proteins selected for the loss of suppression of transformationD C Olson, A J Levine
Psychiatric Services (Washington, D.C.)|April 27, 2000
Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998L Citrome, J Levine, B Allingham
Clinical Research|January 13, 1975
Position statement of the American Federation for Clinical Research on the DHEW proposed rules on protection of human subjectsR J Levine, R A Kreisberg
Pageof 227